Insider Transactions in Q2 2022 at Humacyte, Inc. (HUMA)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 24
2022
|
William John Scheessele Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
10,525
+50.0%
|
$42,100
$4.72 P/Share
|
|
May 23
2022
|
Laura E Niklason President, CEO and Director |
BUY
Open market or private purchase
|
Direct |
10,000
+0.86%
|
$40,000
$4.83 P/Share
|
|
May 23
2022
|
Brady W Dougan Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.86%
|
$40,000
$4.83 P/Share
|
|
May 23
2022
|
Michael T. Constantino Director |
BUY
Open market or private purchase
|
Direct |
2,000
+30.77%
|
$8,000
$4.83 P/Share
|
|
May 17
2022
|
Dale A. Sander CFO and Chief Corp. Deve. Off. |
BUY
Open market or private purchase
|
Direct |
2,000
+50.0%
|
$8,000
$4.53 P/Share
|